Short Post-surgical Antibiotic Therapy in Spine Infections - a Prospective, Randomized, Unblinded, Non-inferiority Trial
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
We implement a prospective, randomized, unblinded, non-inferiority trial regarding the
duration of systemic, targeted antibiotic therapy after the first surgical debridement for
spine infection; randomizing 1:1 between
1. Six and twelve weeks of antibiotic therapy if there is an implant left in place
2. Three and six weeks of antibiotic therapy if there is no implant left